How good is SPDT/SDT therapy?
The first thing to note is that there is no evidence whatsoever of any long term damage from the therapy. This is a huge advantage, because it means that: a. the risks of over treatment are money and time, and not health and longevity. b. the therapy is repeatable. If a patient needs more SPDT/SDT, then the barriers to getting this are access to treatment and money. If a patient needs more chemotherapy or radiation, the barriers may be too much toxicity, or too much damage. With early stage cancer, SPDT/SDT has the same problem with evidence as other therapies. We won’t know for a long time. With late stage cancer, the evidence is much clearer. Many Opal Clinic patients are late stage and most do not have good alternative treatment options. Some have been given up as ” terminal” or “palliative” by other practitioners.
The first thing to note is that there is no evidence whatsoever of any long term damage from the therapy. This is a huge advantage, because it means that: a. the risks of over treatment are money and time, and not health and longevity. b. the therapy is repeatable. If a patient needs more SPDT/SDT, then the barriers to getting this are access to treatment and money. If a patient needs more chemotherapy or radiation, the barriers may be too much toxicity, or too much damage. With early stage cancer, SPDT/SDT has the same problem with evidence as other therapies. We won’t know for a long time. With late stage cancer, the evidence is much clearer. Many Opal Clinic patients are late stage and most do not have good alternative treatment options. Some have been given up as ” terminal” or “palliative” by other practitioners.
